H2020Индивидуална стипендия2020–2022

greenEV · Development of a novel continuous Extracellular Vesicle production system

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2020-12-01 → 2022-11-30
Финансиране от ЕС
183 473 €
Участници
1
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Растителните екстрацелуларни везикули се изследват като естествени наноконтейнери за транспорт на вещества, например лекарства. Използването на растения вместо клетки от бозайници прави производството на тези транспортни системи по-етично, устойчиво и по-лесно за мащабиране.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Development of a novel continuous Extracellular Vesicle production system

Plants have shaped human history and society since the beginning of our joint evolution. With the emerging recognition of world population feeding, global climate change and limited non-renewable energy resources, the relevance of plant biology and biotechnology is becoming increasingly important. In this context, MSCA greenEV project aimed to set the bases for the production, characterization and use of a novel type of nanocarrier that can be isolated from plant resources. A nanocarrier is nanomaterial being used as a transport system for another substance, such as a drug. Commonly used nanocarriers include liposomes, micelles, carbon-based materials, polymers and other synthetic substances. Bio-based materials with novel characteristics however are emerging. Amongst these, there are extracellular vesicles (EVs), biomembrane-enclosed tiny structures that are secreted by living cells. They are natural transporters of proteins, lipids, RNAs and other small molecules. EVs have recently been recognized as an important communication system between close and distant cells and even different organisms. Mammalian cell-derived EVs are under intense exploitation by pharmaceutical industries as high versatility nano-based delivery system. Upscaling of mammalian cell cultures for the EV production is however economically and technologically challenging. Moreover, green resources would better fit to the ethical and sustainable production of EVs with interesting market opportunities. Here comes the main idea of greenEV project to use plant cell suspension cultures (CSCs) for the production of EVs. We have built our project on the following important pillars: 1. Establishment of CSCs of two selected plant species in the beneficiary laboratory for the production of CSC-derived EVs; 2. Setup methods and protocols for the isolation of CSC-derived EVs and perform an in-depth biophysical and biocargo characterization; 3. Load the plant EVs with a selected high-end value natural biomolecule to demonstrate their applicability in pharmaceutical and cosmeceutical sectors. GreenEV has selected two plant species for its research activities: Ginkgo biloba L. (ginkgo) tree and Solanium lycopersicum (tomato) plant. Ginkgo was chosen because of its importance in our human history and culture as well as in plant evolution. Ginkgo tree is living fossil often used in streets and parks for its attractive golden leaves in autumns, but it is also rich in substances with elevated healing properties. Tomato, on the other hand, is one of the most important vegetables for human nutrition and the most accessible natural source of lycopene. GreenEV project has successfully achieved the above main and specific objectives through its 11 deliverables. The results achieved in greenEV have expanded the current knowhow in the plant-derived EV research field. The results obtained in greenEV show translational challenges and opportunities as well as encouraging perspectives towards biotechnological applications.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Functional foods boosted with bioactive nutrients to enhance health and mitigating disease conditions are experiencing an amazing progress. Encapsulation is becoming an important strategy to enhance the bioavailability of poorly absorbed compounds and developing healthy foods. In this context, novel nano-scale approaches to create alternative delivery options for nutraceuticals are emerging. GreenEV aims to develop a continuous plant tissue culturing system for the manufacturing of non-mammalian nanovesicles, and exploit them for the encapsulation, release and bioavailability enhancement of selected nutraceuticals. Plants cells have been shown to physiologically release phospholipid membrane-surrounded vesicles into the apoplast and environment. These vesicles are morphologically similar to mammalian extracellular vesicles (EVs). The process that drive the vesicle formation and their release through the semi-rigid cell wall is not trivial, and will be studied in the greenEV.The experienced researcher is a plant biologist with strong background in plant tissue culturing who team-up with the Institute of Biosciences and BioResources (IBBR) with considerable expertise in EV research to realize a uniquely interdisciplinary research program. The research proposed here will realize the following concrete objectives: 1. Set-up a novel, plant-based EV production system, 2. Employ an integrated analytical pipeline for the isolation, characterization, encapsulation, uptake and toxicological profiling of plant secreted EVs. Neither of these objectives have been addressed before and both have high potential to expand the knowledge in the field and to drive the research activity towards industrialized continuous production of plant EVs. The research objectives are integrated with concerted training objectives in EV research, omics, outreach program, dissemination events and considerable knowledge transfer in plant tissue culturing from the researcher to the IBBR host group.

Оригинален текст от CORDIS (на английски).

Участници

  • CONSIGLIO NAZIONALE DELLE RICERCHE · RomaКоординаторИталия

Връзки

Данни: CORDIS, © Европейски съюз